X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-abacavir-sulfate-dolutegravir-and-lamivudine-tablets-52927.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216332
https://www.fda.gov/drugs/human-immunodeficiency-virus-hiv/food-and-drug-administration-approved-revisions-triumeq-abacavirdolutegravirlamivudine-and-dovato
https://www.fiercebiotech.com/research/five-fda-approved-antivirals-could-target-covid-19-study
https://www.pharmacompass.com/pdf/news/new-paragraph-iv-certifications-as-of-april-7-2020-1586926620.pdf
https://endpts.com/viivs-dovato-wins-speedy-us-approval-with-prv-empowering-gsk-to-muscle-into-gileads-hiv-empire/
https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM293268.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090159
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090159
https://www.pharmacompass.com/pdf/news/List-of-New-Paragraph-IV-Certifications-as-of-Aug-21-2018-1534919998.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077950
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078119
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-triumeq-abacavir-sulfate-dolutegravir-lamivudine-tablets-1506579068.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091144
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204990
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206151
http://www.business-standard.com/article/markets/lupin-gains-on-tentative-approval-for-generic-epzicom-tablets-116112300300_1.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204990
https://www.pharmacompass.com/pdf/news/hetero-labs-ltd-iii-generic-abacavir-sulfate-approved-in-us-1475059837.pdf
http://www.fiercepharma.com/special-reports/top-20-drugs-2020-worldwide-sales
http://www.fiercepharmamarketing.com/story/glaxosmithklines-hiv-bright-spot-could-get-brighter-new-tivicay-combo-meds/2015-11-04
http://www.pmlive.com/pharma_news/viiv_boosted_by_positive_phase_iii_results_for_hiv_drug_triumeq_827872
Market Place
Share 
